Xiaomi, Vivo and Oppo may launch mid-range slimmer handsets The phones could have batteries with a capacity of 4,500mAh or above Samsung Galaxy S25 Edge is tipped to get a Snapdragon 8 Elite SoC ...

Intellia Therapeutics NTLA announced that it has dosed the first patient in the phase III HAELO study evaluating NTLA-2002, its novel in vivo CRISPR gene editing therapy for the treatment of ...

As smartphone cameras continue to evolve, flagship devices like the Samsung Galaxy S25 Ultra, Vivo X200 Pro, and Oppo Find X8 Pro push the boundaries of mobile photography. Each device boasts ...

Telefônica Brasil, known as Vivo, is a leading telecom company in Brazil, excelling in dividend payments and maintaining a strong market presence ...

Samsung held a mega launch event to unveil the Galaxy S25 series of smartphones. There have been reports that the Galaxy S25 ...

Samsung's next flagship camera phone - the Galaxy S25 Ultra - is almost with us, but rumors are already circulating ...

Anyone who downloads Apple's upcoming software updates will have to take a few steps to disable Apple Intelligence.

A new study published in the peer-reviewed journal Muscle & Nerve shows that full-spectrum cannabidiol (CBD) oil may help ...

Apple loses its top spot in China to Huawei and Vivo, facing challenges from local competitors and falling sales.

The biotech said it has dosed the first participant in a Phase 3 study of its in vivo gene editing treatment. Elsewhere, the FDA imposed a hold on Atara and lifted another on Amylyx.

Researchers at CeMM and the Medical University of Vienna have developed an innovative microscopy-based approach that could ...